Item Type: | Editorial |
---|---|
Title: | Solute excretion, metabolism, and cardio-renoprotection via two distinct mechanisms revolutionize clinical outcomes |
Creators Name: | Luft, F.C. |
Abstract: | Two pharmacological principles, one at least 80 years old and another over 60 years old have recently come to fruition. The first, phlorizin, was thought to cause diabetes, but then a closer look revealed a renal mechanism that was independent of insulin or insulin deficiency. Research into its action facilitated the discovery of sodium-dependent glucose transporters. The second compound came close on the heels of the discovery that the mineralocorticoid, aldosterone, can be released through the action of angiotensin II. |
Keywords: | SGLT2, Mineralocorticoid Recepter, Finerenone, Cardiovascular Disease, Chronic Kidney Disease |
Source: | Acta Physiologica |
ISSN: | 1748-1708 |
Publisher: | Wiley |
Volume: | 232 |
Number: | 3 |
Page Range: | e13589 |
Date: | 6 July 2021 |
Official Publication: | https://doi.org/10.1111/apha.13589 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page